ClinDART, Inc. is a boutique, data-focused Contract Research Organization (CRO), offering custom data management and statistical programming solutions for clinical trials in the pharmaceutical, biotech, and medical device industries. Founded in 2008, ClinDART takes a unique approach to trial management, treating each project as a carefully premeditated operation and providing strategic, full-scope consultation on acquiring, managing, and programming data. The company's United States headquarters serve as the base from which they leverage their decades of combined experience and thorough knowledge of the clinical trial process. ClinDART's team of seasoned experts has extensive experience working in a wide range of clinical environments, including large pharmaceutical companies, small biotech firms, as well as academic institutions. The company emphasizes the importance of seamlessly complementing their clients' organizations in the pursuit of their goals within the clinical trial process. While specific details on recent investments and investors are not available, ClinDART's strong emphasis on expertise, efficiency, and cost-effectiveness in managing trial data positions them as an attractive potential partner for venture capitalists looking to invest in the growing field of clinical trial management services. Their commitment to providing strategic consultation, efficient processes, and effective management underscores their potential for long-term success and growth within the industry.
There is no investment information
No recent news or press coverage available for ClinDART, Inc..